Main characteristics of ALCL patients
| ALCL patients (n = 32) . | |
|---|---|
| Characteristic | |
| Median age at diagnosis, y | 13 |
| Male: female ratio | 21:11; 1,7 |
| ALK translocation | |
| + | 22 |
| − | 10 |
| Ann Arbor stage | |
| I | 5 |
| II | 6 |
| III | 5 |
| IV | 6 |
| NC | 10 |
| Elevated serum LDH, % (n/N) | 62 |
| IPI score | |
| 0 | 4 |
| 1 | 5 |
| 2 | 4 |
| 3 | 6 |
| 4 | 0 |
| 5 | 0 |
| NC | 13 |
| OS of total cohort, % (n/N) | |
| 1 y | 83,3 |
| 3 y | 62,5 |
| Complete remission, % (n/N) | 91,3 |
| ALCL patients (n = 32) . | |
|---|---|
| Characteristic | |
| Median age at diagnosis, y | 13 |
| Male: female ratio | 21:11; 1,7 |
| ALK translocation | |
| + | 22 |
| − | 10 |
| Ann Arbor stage | |
| I | 5 |
| II | 6 |
| III | 5 |
| IV | 6 |
| NC | 10 |
| Elevated serum LDH, % (n/N) | 62 |
| IPI score | |
| 0 | 4 |
| 1 | 5 |
| 2 | 4 |
| 3 | 6 |
| 4 | 0 |
| 5 | 0 |
| NC | 13 |
| OS of total cohort, % (n/N) | |
| 1 y | 83,3 |
| 3 y | 62,5 |
| Complete remission, % (n/N) | 91,3 |